Novabay Pharmaceuticals, Inc.
NBY
Revenue
6.32M
▲2.23M▲54.39%
3 Months ChangeAssets
3.42M
▼-454.00k▼-11.71%
3 Months ChangeLiabilities
3.55M
▲747.00k▲26.63%
3 Months ChangeFree Cash Flow
-1.57M
▼-374.00k▼-31.17%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-29
Form 8-K
ID: 0001437749-24-032365
2024-10-16
Form 8-K
ID: 0001437749-24-031362
2024-09-20
Form 8-K
ID: 0001437749-24-029642
2024-08-13
Form 10-Q
ID: 0001437749-24-026386
2024-07-29
Form 8-K
ID: 0001437749-24-023740
2024-07-11
Form 8-K
ID: 0001437749-24-022526
2024-06-14
Form 8-K
ID: 0001437749-24-020277
2024-06-07
Form 8-K
ID: 0001437749-24-019536
2024-05-31
Form 8-K
ID: 0001437749-24-018930
2024-05-29
Form 8-K
ID: 0001437749-24-018612